Terms ending in 2034
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,180,185 | Combination Therapy of ANTI-HER3 Antibodies In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,862,779 | Method for the Production and Selection of Molecules Comprising at Least Two Different Entities and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,405,069 | Method For Preparing An Outer Surface Of A Planar Waveguide To Be Capable Of Binding Target Samples Along A Plurality Of Predeterminded Lines And A Planar Waveguide In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,427,427 | Pharmaceutical Composition with Improved Bioavailability In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,034,854 | Pharmaceutical Composition with Improved Bioavailability In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 10,253,022 | Process for the Preparation of N-[(3-Aminooxetan-3-YL) METHYL]-2-(1,1-Dioxo-3,5-Dihydro-1,4-Benzothiazepin-4-YL)-6-Methyl-QUINAZOLIN-4-Amine In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 9,925,272 | Anti-Theophylline Antibodies and Methods of Use In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,963,511 | Expression Vector Organization, Novel Production Cell Generation Methods and Their Use for the Recombinant Production of Polypeptides In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,828,340 | Asymmetric Synthesis of a Substituted PYRROLIDINE-2-Carboxamide In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,633,451 | Bispecific Antibody Molecules with Antigen-Transfected T-Cells and Their Use in Medicine In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 63 more term ends in 2034 · Pro | |||||
10 of 73 patents shown. Soonest term end first, then patent number.
Pro members see all 73.
63 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.